Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Journal of Medicinal Chemistry|November 3, 2020
A Novel N-Substituted Valine Derivative with Unique Peroxisome Proliferator-Activated Receptor γ Binding Properties and Biological ActivitiesFranck Peiretti, Roberta Montanari, Davide Capelli, et al.Chemmedchem|February 3, 2015
On the metabolically active form of metaglidasen: improved synthesis and investigation of its peculiar activity on peroxisome proliferator-activated receptors and skeletal musclesAntonio Laghezza, Roberta Montanari, Antonio Lavecchia, et al.European Journal of Medicinal Chemistry|May 3, 2025
Enhancing the activity of γ-hydroxy lactone derivatives as innovative peroxisome proliferator-activated receptor γ non-agonists inhibiting cyclin-dependent kinase 5-mediated phosphorylationGiulia Cazzaniga, Davide Capelli, Roberta Montanari, et al.Pharmaceuticals (Basel, Switzerland)|July 2, 2021
Discovery of Novel Chemical Series of OXA-48 β-Lactamase Inhibitors by High-Throughput ScreeningBarbara Garofalo, Federica Prati, Rosa Buonfiglio, et al.Frontiers in Chemistry|January 31, 2020
Surface Plasmon Resonance as a Tool for Ligand Binding Investigation of Engineered GPR17 Receptor, a G Protein Coupled Receptor Involved in MyelinationDavide Capelli, Chiara Parravicini, Giorgio Pochetti, et al.The FEBS Journal|October 25, 2021
Cytosolic localization and in vitro assembly of human de novo thymidylate synthesis complexSharon Spizzichino, Dalila Boi, Giovanna Boumis, et al.Journal of Medicinal Chemistry|April 3, 2020
Insights into PPARγ Phosphorylation and Its Inhibition MechanismRoberta Montanari, Davide Capelli, Keiko Yamamoto, et al.International Journal of Molecular Sciences|December 10, 2021
PHA-680626 Is an Effective Inhibitor of the Interaction between Aurora-A and N-MycDalila Boi, Fani Souvalidou, Davide Capelli, et al.European Journal of Medicinal Chemistry|June 12, 2024
A chemical modification of a peroxisome proliferator-activated receptor pan agonist produced a shift to a new dual alpha/gamma partial agonist endowed with mitochondrial pyruvate carrier inhibition and antidiabetic propertiesAntonio Laghezza, Carmen Cerchia, Massimo Genovese, et al.ACS Pharmacology & Translational Science|July 20, 2023
Novel N-(Heterocyclylphenyl)benzensulfonamide Sharing an Unreported Binding Site with T-Cell Factor 4 at the β-Catenin Armadillo Repeats Domain as an Anticancer AgentMarianna Nalli, Laura Di Magno, Yichao Wen, et al.Pageof 3